Apoptosis and clinical severity in patients with psoriasis and HCV infection

Background: It has been proposed that hepatitis C virus (HCV) antigens are involved in the pathogenesis of psoriasis and may contribute to severity of the disease. Increased expression of the apoptosis-regulating proteins p53 and tTG and decreased levels of bcl-2 in the keratinocytes of the skin of...

Full description

Bibliographic Details
Main Authors: Sami A Gabr, Mohamed A Berika, Ahmad H Alghadir
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2014-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2014;volume=59;issue=3;spage=230;epage=236;aulast=Gabr
_version_ 1818110755590897664
author Sami A Gabr
Mohamed A Berika
Ahmad H Alghadir
author_facet Sami A Gabr
Mohamed A Berika
Ahmad H Alghadir
author_sort Sami A Gabr
collection DOAJ
description Background: It has been proposed that hepatitis C virus (HCV) antigens are involved in the pathogenesis of psoriasis and may contribute to severity of the disease. Increased expression of the apoptosis-regulating proteins p53 and tTG and decreased levels of bcl-2 in the keratinocytes of the skin of psoriatic patients have been reported. Aim: This study aims to identify the serum levels of apoptosis-regulating proteins in patients with psoriasis and without HCV infection and to study the relation between clinical severity of psoriasis and the presence of HCV infection. Materials and Methods: Disease severity was assessed by psoriasis area severity index score (PASI) of 90 patients with psoriasis grouped as mild (n = 30), moderate (n = 30) and severe (n = 30); 20 healthy individuals were used as controls. All groups were subjected for complete history taking, clinical examination, and tests for liver function and HCV infection. The serum levels of apoptosis related proteins: p53, tTG and bcl-2 were estimated by enzyme linked immune sorbent assay (ELISA). Results: There was a statistically significant (P < 0.001) correlation between clinical severity of psoriasis and presence of HCV antibodies and HCV-mRNA. In addition, significantly (P < 0.001) raised serum p53 and tTG, and reduced bcl-2 were observed among HCV-positive patients as compared to HCV-negative patients and control patients. Conclusion: These results conclude that clinical severity of psoriasis is affected by the presence of HCV antibodies and overexpression of apoptotic related proteins. In addition, altered serum levels of apoptosis-regulating proteins could be useful prognostic markers and therapeutic targets of psoriatic disease.
first_indexed 2024-12-11T02:52:11Z
format Article
id doaj.art-17226fe0add24c969bf7d539ef46b521
institution Directory Open Access Journal
issn 0019-5154
1998-3611
language English
last_indexed 2024-12-11T02:52:11Z
publishDate 2014-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Dermatology
spelling doaj.art-17226fe0add24c969bf7d539ef46b5212022-12-22T01:23:16ZengWolters Kluwer Medknow PublicationsIndian Journal of Dermatology0019-51541998-36112014-01-0159323023610.4103/0019-5154.131377Apoptosis and clinical severity in patients with psoriasis and HCV infectionSami A GabrMohamed A BerikaAhmad H AlghadirBackground: It has been proposed that hepatitis C virus (HCV) antigens are involved in the pathogenesis of psoriasis and may contribute to severity of the disease. Increased expression of the apoptosis-regulating proteins p53 and tTG and decreased levels of bcl-2 in the keratinocytes of the skin of psoriatic patients have been reported. Aim: This study aims to identify the serum levels of apoptosis-regulating proteins in patients with psoriasis and without HCV infection and to study the relation between clinical severity of psoriasis and the presence of HCV infection. Materials and Methods: Disease severity was assessed by psoriasis area severity index score (PASI) of 90 patients with psoriasis grouped as mild (n = 30), moderate (n = 30) and severe (n = 30); 20 healthy individuals were used as controls. All groups were subjected for complete history taking, clinical examination, and tests for liver function and HCV infection. The serum levels of apoptosis related proteins: p53, tTG and bcl-2 were estimated by enzyme linked immune sorbent assay (ELISA). Results: There was a statistically significant (P < 0.001) correlation between clinical severity of psoriasis and presence of HCV antibodies and HCV-mRNA. In addition, significantly (P < 0.001) raised serum p53 and tTG, and reduced bcl-2 were observed among HCV-positive patients as compared to HCV-negative patients and control patients. Conclusion: These results conclude that clinical severity of psoriasis is affected by the presence of HCV antibodies and overexpression of apoptotic related proteins. In addition, altered serum levels of apoptosis-regulating proteins could be useful prognostic markers and therapeutic targets of psoriatic disease.http://www.e-ijd.org/article.asp?issn=0019-5154;year=2014;volume=59;issue=3;spage=230;epage=236;aulast=GabrApoptosisB cell lymphoma-2 proteinHepatitis C virusP53Psoriasistissue transglutaminase
spellingShingle Sami A Gabr
Mohamed A Berika
Ahmad H Alghadir
Apoptosis and clinical severity in patients with psoriasis and HCV infection
Indian Journal of Dermatology
Apoptosis
B cell lymphoma-2 protein
Hepatitis C virus
P53
Psoriasis
tissue transglutaminase
title Apoptosis and clinical severity in patients with psoriasis and HCV infection
title_full Apoptosis and clinical severity in patients with psoriasis and HCV infection
title_fullStr Apoptosis and clinical severity in patients with psoriasis and HCV infection
title_full_unstemmed Apoptosis and clinical severity in patients with psoriasis and HCV infection
title_short Apoptosis and clinical severity in patients with psoriasis and HCV infection
title_sort apoptosis and clinical severity in patients with psoriasis and hcv infection
topic Apoptosis
B cell lymphoma-2 protein
Hepatitis C virus
P53
Psoriasis
tissue transglutaminase
url http://www.e-ijd.org/article.asp?issn=0019-5154;year=2014;volume=59;issue=3;spage=230;epage=236;aulast=Gabr
work_keys_str_mv AT samiagabr apoptosisandclinicalseverityinpatientswithpsoriasisandhcvinfection
AT mohamedaberika apoptosisandclinicalseverityinpatientswithpsoriasisandhcvinfection
AT ahmadhalghadir apoptosisandclinicalseverityinpatientswithpsoriasisandhcvinfection